APG-2449 in Patients With Advanced Solid Tumors

Conditions:   Advanced Solid Cancer;   Non Small Cell Lung Cancer;   Esophageal Cancer;   Ovarian Cancer;   Malignant Pleural Mesothelioma Intervention:   Drug: APG-2449 Sponsor:   Ascentage Pharma Group Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials